CFDA: Yet another story? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-12 09:09 (1061 d 23:11 ago) – Posting: # 18887
Views: 4,586

Hi Helmut,

thanks for your help.

CFDA has relased the draft guidance for HVBE, which follows FDA method (RSABE).

I still have a question about EMA method. Do you mean if we follow EMA's guidance, the ABEL should be used rather than RSABE, please give me more advise.

thanks in advance. :-D:-D:-D

Complete thread:

Activity
 Admin contact
21,445 posts in 4,482 threads, 1,510 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Sunday 08:21 UTC (Europe/Vienna)

It is better to know some of the questions
than all of the answers.    James Thurber

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5